Eli Lilly | LLY - نسبة السعر إلى الأرباح





Pe تغيير تاريخ
AbbVie 23.03 1 2026-03
Abbott 24.94 5.78 2026-03
ALKERMES 39.33 19.8 2026-03
Amgen 19.84 5.47 2026-03
AstraZeneca 29.59 2.3 2026-03
Baxter International 86 68.9 2025-12
Biogen 13.7 0.32 2026-03
Bristol-Myers Squibb 9.08 0.2 2026-03
Drreddys Laboratories 18.27 0.84 2025-12
Eli Lilly 40.27 0.06 2026-03
Gilead Sciences 17.7 2.07 2026-03
GlaxoSmithKline 14.87 3.72 2026-03
Glaxosmithkline 11.66 0.28 2025-12
J&J 24.53 0.91 2026-03
Medtronic 19.66 3.1 2026-03
Merck 16.52 2.6 2026-03
Neurocrine Biosciences 28.09 807.38 2026-03
Novartis 20.17 2.32 2026-03
Novartis 17.79 1.74 2025-12
Novo Nordisk 12.78 0.01 2025-12
Perrigo 27.45 31.51 2026-03
Pfizer 9.32 5.16 2026-03
Phibro Animal Health 13.82 4.04 2025-12
Prestige Brands 15.31 3.1 2025-12
Regeneron Pharmaceuticals 25.14 7.03 2026-03
Roche Holding 16.09 3.51 2025-12
Sanofi 11.84 0.14 2026-03
Sanofi 15.75 1.53 2025-12
United Therapeutics 20.42 3.1 2026-03
Zoetis 18.8 1.62 2026-03